ODOBGYNDECODED

← Clinical library

Obstetrics

VBAC / TOLAC

IN REVIEWv2🌍 International referencePENDING CLINICAL VERIFICATION⚡ Uterine Rupture
One prior lower-segment caesarean, no contraindications -> OFFER TOLAC (success 72-75%; rupture ~0.5%). Excluded: classical/J scar, prior rupture, extensive transfundal surgery. Continuous CTG + instant theatre are non-negotiable.

Admission & discharge ↓

Reviewer note: Admission/discharge guidance checked 18 October 2026. This adds a scoped clinical synthesis and does not certify every statement in the module.

Clinical detail

Additional detail checked 2026-10-17 against the linked sources. This check covers the section below; the rest of the module retains its displayed verification status.

Birth after a caesarean needs an individual discussion of planned vaginal birth and repeat caesarean birth.

Assessment & interpretation

  • Review the previous operation and the patient’s priorities, and assess factors that may alter the safety or likelihood of vaginal birth.

Decisions that change management

  • Planned vaginal birth has a higher uterine-rupture risk than planned repeat caesarean.
  • NICE advises electronic fetal monitoring and care where immediate caesarean birth and on-site blood transfusion are available.
  • Induction after caesarean requires closer monitoring and an explicit discussion of rupture risk and the chosen method.

Follow-up & safety-netting

  • Document the plan and the circumstances that would trigger reassessment, including labour before a scheduled repeat caesarean.
Sources for this detail:

Admission & discharge

Care setting: Birth-facility care for established labour; postnatal discharge requires mother-and-baby assessment

Admission/discharge guidance checked 2026-10-18 against the linked sources. This is a clinical checklist for an individual decision, not an automatic discharge order.

When admission or continued hospital care is needed

  • Established labour/birth, concerning maternal observations, abnormal fetal assessment, significant bleeding, rupture of membranes with risk factors, or a need for analgesia/monitoring requires the appropriate maternity setting.
  • Scar pain, collapse, bleeding or fetal bradycardia during TOLAC requires urgent assessment for rupture and operative care.

When clinic, day care or home care may be suitable

  • Latent labour may be managed at home only after assessment excludes complications and the woman has a safe return plan. TOLAC requires a facility with immediate access to caesarean/transfusion when labour is established.

Before going home

  • After an uncomplicated vaginal birth, the Indian NHM pathway keeps the woman under observation for at least 48 hours. The international WHO minimum is 24 hours; local clinical needs may require longer.
  • Before home care assess bleeding/uterine tone, observations, pain/perineum, bladder function and mobility; assess the newborn separately and observe an effective feed or document a safe feeding plan.

Discharge medicines and treatment changes

  • Reconcile prescribed postnatal supplements, pain relief and any indicated VTE/anti-D care. Routine birth does not create a blanket need for take-home antibiotics.
  • For TOLAC ending in caesarean or a significant complication, use that recovery/discharge pathway instead of the uncomplicated vaginal-birth timetable.
Medicine doses — use only when indicated

Use the medicines selected for this patient. Listed alternatives are not instructions to prescribe all of them together. Confirm the actual remaining course, pregnancy/postnatal context and monitoring plan.

For maternal pain when prescribed.

Paracetamol (acetaminophen) — oral pain reliefMédecins Sans Frontières · Current online monographchecked
Dose1 g (two 500 mg tablets) per dose
RouteOral
FrequencyEvery 6–8 hours when needed; maximum 4 doses in 24 hours
DurationAccording to clinical response: reduce/stop as pain improves. Record the prescribed supply and review date; persistent or increasing pain needs reassessment rather than an automatic repeat course.
PreparationCheck tablet strength: two 500 mg tablets = 1 g. Count paracetamol in every combination/OTC product towards the total; this is not an IV preparation.
Max dose4 g in 24 hours for the stated adult population. Lower weight, hepatic impairment or other risk factors require an individual reduced prescription; do not automatically use this maximum.
  • Indication: Short-term maternal postoperative/postpartum pain or other mild pain after assessment; adult ≥50 kg
  • MSF oral monograph: no pregnancy or breastfeeding contraindication. The dose does not replace assessment of the cause of pain.
Monitoring
  • Pain and functional recovery; investigate increasing pain, fever or other warning symptoms.
  • Check all prescribed/OTC paracetamol, weight and hepatic risk; suspected excess dosing requires urgent assessment.
Contraindications: Paracetamol allergy; avoid duplicate paracetamol-containing products. · Hepatic impairment needs caution and a clinician-adjusted regimen. This adult ≥50 kg card is not a weight-based prescription for smaller adults or children.

Postpartum only when bleeding, renal and other contraindications have been excluded.

Ibuprofen — postpartum/nonpregnant postoperative painMédecins Sans Frontières · Current online monographchecked
Dose200–400 mg per dose
RouteOral
FrequencyEvery 8 hours when prescribed; reduce/stop as symptoms improve
DurationShortest course needed for recovery; MSF postoperative reference maximum 8 days. Record the actual stop/review date; ongoing or increasing pain needs clinical review.
PreparationCheck 200 mg or 400 mg tablet strength. Take with food; do not combine with another NSAID or duplicate OTC ibuprofen.
Max dose1,200 mg in 24 hours in this pain regimen; do not import higher anti-inflammatory schedules into a discharge prescription.
  • Indication: Short-term pain relief after birth or gynaecological surgery when NSAIDs are appropriate; not an antenatal regimen
  • Short-term use is compatible with breastfeeding in the MSF reference. Do not prescribe while bleeding or renal contraindications remain unresolved.
Monitoring
  • Pain response, hydration/urine output, GI pain or bleeding; review renal function when clinically indicated.
  • Check current bleeding, renal/hepatic function, allergy/asthma history, anticoagulants and interacting medicines before prescribing.
Contraindications: NSAID allergy or NSAID-triggered asthma; active peptic ulcer/GI bleeding or a significant bleeding/coagulation problem. · Severe renal/hepatic impairment, severe heart failure, uncorrected dehydration/hypovolaemia or severe infection. Avoid in OHSS because of renal risk. · Avoid concurrent NSAIDs; anticoagulants, methotrexate, ACE inhibitors/diuretics and other interacting medicines require prescriber review. This card is for postpartum/nonpregnant care, not pregnancy.

Tests, pending results and their reviewer

  • Review maternal risk/results and the need for Hb testing after significant blood loss. Record any maternal/newborn screening or result still outstanding and its reviewer.

Home care and counselling

  • Discuss lochia, hygiene/perineal or wound care, bladder/bowel recovery, feeding support, contraception, pelvic-floor exercise and emotional wellbeing; give the maternity contact/transport plan.
  • Document the birth outcome and operative findings, explain future birth implications and give access to a birth debrief.

Follow-up: when and what to review

WhenAction / responsible service
Within 36 hours after transfer (NICE service model)
Arrange the first face-to-face postnatal contact; the local Indian service may organise this differently.
WHO routine contacts: 48–72 hours, day 7–14 and week 6 after birth
Ensure the actual appointment/home-visit arrangements are recorded; add earlier reviews for complications.

Return urgently

  • Heavy/increasing bleeding, fainting, fever/offensive lochia, worsening pain, severe headache/visual symptoms, dyspnoea/chest pain or unilateral leg swelling need urgent care.
  • A baby with poor feeding, abnormal breathing, unusual sleepiness, temperature concerns or early/worsening jaundice needs prompt newborn assessment.

Open the complete discharge checklist →

Treatment

① Immediate stabilization — first minutes
Suspected rupture: Stop oxytocin · senior+anaesthetist NOW · category-1 caesarean · two IVs + crossmatch running · MTP primed
③ First-line treatment & drug regimens
  • Spontaneous labour preferred (highest success, lowest rupture)
  • Induction acceptable with oxytocin/mechanical methods after counselling; prostaglandins (esp. misoprostol/PGE2) avoided in scarred uterus
  • Continuous electronic fetal monitoring throughout active labour
  • Low threshold for assisted second stage
Definitive treatment

Vaginal birth (VBAC) or conversion to caesarean - both valid endpoints; document decision points.

Monitoring
DomainRule
CTG
Continuous from active labour
Progress
Strict partogram - poor progress converts earlier
Symptoms
Pain/bleeding/station loss each assessment
Access
IV in situ; group&save done; theatre aware
Treatment failure
  • Rupture -> laparotomy + repair/hysterectomy decision; neonatal cooling-capable nursery coordination
  • Arrest disorders -> repeat caesarean rather than heroic augmentation
Escalation
  • Consultant presence per institutional policy
  • Blood bank notified at admission
⑮ Complications & their management
Uterine rupture (~0.5%)

As above; MTP early

Neonatal hypoxic injury

Therapeutic cooling pathway liaison

Post-treatment care
  • Successful VBAC standard care; failed -> CS bundle
  • Future rupture risk drops sharply after successful VBAC - counsel

Diagnosis & assessment

Red flags:
  • RUPTURE SIGNS: abnormal CTG (commonest FIRST sign), loss of station, scar pain, haematuria, contractions ceasing, maternal tachycardia/hypotension
  • Fetal bradycardia during TOLAC = rupture until proven otherwise -> category-1 caesarean

Definition: Trial of labour after caesarean. Best success predictors: prior vaginal birth, spontaneous labour, BMI<30, non-recurrent index indication.

Initial assessment

  1. Review index operative note (incision TYPE decisive)
  2. Eligibility + documented shared decision
  3. Facility capability confirmed: continuous CTG + immediate theatre (many Indian centres mandate in-house readiness)

Investigations

TestLooking for
Index scar documentation
Lower-segment confirmed

Sources (10)

NICE — Intrapartum care (NG235)
2023-09-29 · updated 2026-06-09 · checked 2026-08-23 · verified-live
Open source ↗

NICE overview + Update information page (dates above confirmed)

NICE — NG192 — caesarean birth
31 March 2021 · updated 10 June 2025 · checked 2026-10-18 · verified-live
Open source ↗

Scope: additional clinical-detail explanation for lscs, vbac-tolac. Checked the assessment, management-decision and follow-up statements in that section against this source. This does not certify all pre-existing regimens, calculations or recommendations in the module. Additional admission/discharge…

NICE — Intrapartum care — full NG235 recommendations
· checked 2026-10-18 · verified-live
Open source ↗

Full primary PDF downloaded; term prelabour rupture, selected expectant care and induction around 24 hours, temperature/return precautions, maternal post-birth assessment and newborn observation after prolonged membrane rupture checked. This is scoped to the implemented admission/transfer recommenda…

NICE — Postnatal care — NG194
· checked 2026-10-18 · verified-live
Open source ↗

Maternal/newborn transfer assessment, first void and effective feeding, handover, support/safeguarding, first midwife visit within 36 hours after transfer, postnatal danger symptoms. Full recommendations page read.

India MoHFW / NHM — District Hospital Standard Operating Procedures — LaQshya
· checked 2026-10-18 · verified-live
Open source ↗

Normal-delivery discharge not less than 48 hours: full primary SOP PDF normal-delivery/discharge passages read. Corroborated by NHM CEmONC 2024 Part 1, chapter 8. This does not define a universal post-caesarean or complicated-case stay.

WHO — WHO recommendations on quality postnatal care — official recommendation summary
· checked 2026-10-18 · verified-live
Open source ↗

Official WHO summary read: at least 24-hour facility care after birth; additional contacts at 48–72 hours, 7–14 days and week 6; individual assessment/support. Summary facts only, not a claim that the full 242-page PDF was reviewed.

Médecins Sans Frontières — Paracetamol (acetaminophen) oral — Essential Drugs
· checked 2026-10-18 · verified-live
Open source ↗

Full primary oral monograph read: adult 1 g 3–4 times daily, maximum 4 g/day, ≥50 kg adult table, 500 mg tablets, duration according to response, hepatic caution and pregnancy/breastfeeding. Pain chapter also checked for 6–8-hour interval. Smaller adults require an individual weight-based prescripti…

Médecins Sans Frontières — Ibuprofen oral — Essential Drugs
· checked 2026-10-18 · verified-live
Open source ↗

Full primary monograph read: pain 200–400 mg, maximum 1200 mg/day; postoperative every 8 hours, maximum 8 days; meals/formulations, renal/GI/bleeding/dehydration/infection contraindications and interactions, short-term breastfeeding. New card restricted to postpartum/nonpregnant care; OHSS renal cau…

RCOG — Laparoscopy — recovering well
· checked 2026-10-18 · verified-live
Open source ↗

Full primary patient recovery page read: pain control, wounds, activity/VTE, urinary/bowel and infection warning signs, adult support and no driving/important decisions during the first 24 hours after general anaesthesia. Used as general recovery/handover principles, not operation-specific discharge…

NICE — Acutely ill adults in hospital — CG50
· checked 2026-10-18 · verified-live
Open source ↗

Full primary recommendations read, focusing on critical-care-to-ward transfer: structured written handover, shared plan, monitoring, rehabilitation and receiving-team capability. Step-down is distinct from home discharge; no universal organ-support discharge cutoff is asserted.